Skip to main content
. Author manuscript; available in PMC: 2012 Nov 17.
Published in final edited form as: Eur J Cancer. 2011 Mar 14;47(12):1808–1816. doi: 10.1016/j.ejca.2011.02.007

Table 3.

Odds ratios and 95% confidence intervals for methionine levels (sex-specific quintiles) and risk of pancreatic cancer by years of follow-up before cancer diagnosis

Methionine (μmol/L) All <=4 years >4 years
Controls Cases OR 95% CI Controls Cases OR 95% CI Controls Cases OR 95% CI
q1 92 106 1.0 31 49 1.0 61 57 1.0
q2 92 75 0.8 (0.5–1.3) 31 36 0.6 (0.3–1.4) 61 39 1.0 (0.5–1.8)
q3 93 84 0.8 (0.5–1.3) 36 20 0.3 (0.1–0.7) 57 64 1.3 (0.7–2.3)
q4 92 93 1.0 (0.6–1.7) 33 29 0.5 (0.2–1.1) 59 64 1.4 (0.8–2.6)
q5 92 103 1.0 (0.6–1.6) 40 39 0.4 (0.2–1.0) 52 64 1.5 (0.9–2.8)
every quintile 1.0 (0.9–1.1) 0.8 (0.7–1.0) 1.1 (1.0–1.3)
p for heterogeneity 0.02
Men
<=21.01 44 36 1.0 14 18 1.0 30 18 1.0
21.01–24.39 44 46 2.3 (1.1–4.9) 16 20 1.4 (0.4–4.4) 28 26 4.1 (1.4–12.0)
24.39–27.87 45 44 1.8 (0.9–3.8) 17 12 0.7 (0.2–2.5) 28 32 3.9 (1.4–10.8)
27.87–31.50 44 38 2.2 (1.0–4.8) 18 11 0.6 (0.2–2.5) 26 27 5.1 (1.6–16.1)
>31.50 44 57 2.5 (1.2–5.4) 21 27 1.2 (0.4–3.9) 23 30 4.9 (1.6–14.8)
every quintile 1.2 (1.0–1.4) 1.0 (0.8–1.3) 1.4 (1.1–1.7)
p for heterogeneity 0.05
Women
<=20.37 48 70 1.0 17 31 1.0 31 39 1.00
20.37–22.42 48 29 0.3 (0.2–0.7) 15 16 0.2 (0.03–1.2) 33 13 0.3 (0.1–0.8)
22.42–25.23 48 40 0.4 (0.2–0.8) 19 8 0.1 (0.02–0.7) 29 32 0.6 (0.2–1.4)
25.23–28.62 48 55 0.6 (0.3–1.1) 15 18 0.3 (0.06–1.5) 33 37 0.7 (0.3–1.7)
>28.62 48 46 0.5 (0.3–1.0) 19 12 0.1 (0.01–0.5) 29 34 0.8 (0.4–1.8)
every quintile 0.9 (0.8–1.0) 0.7 (0.5–0.9) 1.0 (0.8–1.2)
p for heterogeneity 0.3
p for heterogeneity by sex <0.01 0.1 <0.01

The OR were estimated from conditional logistic regression based on matching factors and further adjustments for education, smoking status, cotinine concentration in plasma, baseline alcohol drinking, BMI and self-reported diabetes status at baseline.